SLFN11 Enhances Cisplatin Sensitivity in Pediatric Cancer via Activation of Stress-Response and Suppression of Survival Pathways
Ayesha Jabeen, Dina Awartani, Shimaa Sherif, Eiman I. Ahmed, Rania Alanany, Ayman Saleh, Wouter Hendrickx, Christophe Michel Raynaud
This study shows SLFN11 enhances cisplatin sensitivity in pediatric cancers by modulating stress-response and survival pathways through epigenetic regulation and functional assays.
British Journal of Cancer · Sep 2, 2026Peer-reviewedCancer Biology